Growth inhibition in HepG2 cells
Cell-based study · HepG2 cells [1]
The growth inhibition of HCPT injections against HepG2 cells: IC50 value: 0.6000 μg/mL. The plates were incubated for 24 h.
| Endpoint | Reported result | Reference |
|---|---|---|
| growth inhibition; IC50 | IC50 HepG2 cells; 24 h: IC50 = 0.6000 μg/mL | [1] |
Literature-Reported Treatment Conditions
- Exposure duration
- 24 h
- Method
- The medium was then replaced with 200 μL HCPT-NSps or HCPT injections
- Reported limits
- Not stated in the sentences used: dose, vehicle.
Methods and source locations
Compound reported in the paper: (S)-10-Hydroxycamptothecin; Compound label in the paper: HYDROXYCAMPTOTHECIN
Evidence for (S)-10-Hydroxycamptothecin as the sodium form reported in the paper, not the free base/neutral form supplied as A11997; no salt equivalence, dose conversion or lot validation.
Material and methods > Materials (S3); Material and methods > Cytotoxicity assay and cellular uptake (S64, S65, S66); Figure 5 legend (S97)
growth inhibition; IC50: growth inhibition; IC50; comparator: HCPT-NSps — Material and methods > Cytotoxicity assay and cellular uptake (S65); Figure 5 legend (S97)